Acein

Acein is a novel nonapeptide, H-Pro-Pro-Thr-Thr-Thr-Lys-Phe-Ala-Ala-OH. Acein can promote the release of dopamine. Acein targets angiotensin converting enzyme (ACE I) . Angiotensin converting enzyme (ACE I) can be used in nervous system related research[1].

Product Specifications

CAS Number

[2022202-76-0]

UNSPSC

12352209

Target

Dopamine Receptor

Type

Peptides

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/acein.html

Smiles

O=C(N1[C@@H](CCC1)C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CCCCN)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](C)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H]3NCCC3

Molecular Formula

C43H68N10O13

Molecular Weight

933.06

References & Citations

[1]Neasta J, et al. The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release. Br J Pharmacol. 2016 Apr;173 (8) :1314-28.